Skip to content
healthcare.dev
Get a free key

CYFENDUS

NDC 71665-001, Anthrax Vaccine Adsorbed, Adjuvanted, injection, suspension, from Emergent Product Development Gaithersburg Inc..

Product NDC
71665-001
Status
Listed
Labeler
Emergent Product Development Gaithersburg Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125761
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71665-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS100 ug/mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Anthrax Vaccines [Chemical/Ingredient]; Live Attenuated Bacillus Anthracis Vaccine [EPC]; Vaccines, Attenuated [Chemical/Ingredient]

Package NDCNDC-11Package
71665-001-02716650001021 VIAL, MULTI-DOSE in 1 CARTON (71665-001-02) / 5 mL in 1 VIAL, MULTI-DOSE (71665-001-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 71665-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71665-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71665-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.